Skip to main content
JEONJINBIO CO., LTD. logo

JEONJINBIO CO., LTD. — Investor Relations & Filings

Ticker · 110020 ISIN · KR7110020005 KO Manufacturing
Open in API
Filings indexed 371 across all filing types
Latest filing 2024-02-13 Legal Proceedings Report
Country KR South Korea
Listing KO 110020

About JEONJINBIO CO., LTD.

http://jjbious.com/01

JEONJINBIO CO., LTD. is a biotechnology company specializing in the research, development, and production of products for pest control and the mitigation of damage from nuisance animals. The company's core offerings consist of natural bio-pesticides and repellents formulated from natural materials as alternatives to conventional chemical products. Its product line includes specialized solutions for repelling birds, boars, and other animals. The company emphasizes innovation and safety, supported by its dedicated research and development center and various product certifications, including USA EPA approval for its bird repellent.

Recent filings

Filing Released Lang Actions
파생상품거래손실발생
Legal Proceedings Report Classification · 100% confidence The document is a regulatory disclosure from a Korean company (Jeonjin BioPharm) regarding a 'Derivative Trading Loss' (파생상품거래손실발생). This is a specific type of material event disclosure required by the Korea Exchange (KRX). Since it does not fit into specific categories like M&A, dividends, or share repurchases, and is a formal regulatory announcement of a financial event, it falls under the 'Regulatory Filings' category.
2024-02-13 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in ownership, and the purpose of holding (management influence) by a major shareholder. This corresponds to the 'Major Shareholding Notification' category.
2024-02-05 Korean
[기재정정]전환청구권행사
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) regarding the exercise of conversion rights (전환청구권행사) for convertible bonds. It details the number of shares to be issued, the conversion price, and the updated listing date. This type of filing relates to changes in capital structure and the issuance of new shares resulting from the conversion of debt into equity, which falls under the 'Share Issue/Capital Change' category.
2024-01-31 Korean
[기재정정]전환청구권행사
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) system regarding the exercise of conversion rights (전환청구권행사) for convertible bonds (CB). This involves the issuance of new shares resulting from the conversion of debt into equity, which directly impacts the company's capital structure. According to the provided definitions, announcements regarding new share issues or capital changes fall under the 'Share Issue/Capital Change' (SHA) category.
2024-01-31 Korean
임시주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official announcement regarding the results of an Extraordinary General Meeting (EGM) for the company '전진바이오팜'. It details the agenda items (such as changes to the articles of incorporation and appointment of directors) and explicitly states that the meeting was adjourned to a later date (연회). This falls under the category of Declaration of Voting Results & Voting Rights Announcements, as it reports the outcome of a shareholder meeting.
2024-01-31 Korean
[기재정정]최대주주변경을수반하는주식양수도계약체결
Major Shareholding Notification Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) system regarding a 'Change in Largest Shareholder' via a stock purchase agreement. It specifically details a correction (amendment) to the payment schedule of the share transfer agreement. This type of corporate disclosure regarding changes in control and shareholding structure is classified as a Regulatory Filing (RNS) in our taxonomy, as it does not fit into specific categories like Director's Dealing or Major Shareholding Notification (which usually refer to individual trades or threshold crossings rather than the corporate-level agreement of a change in control).
2024-01-29 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.